Thyroid Disease CARE Act of 2025
Summary
What This Bill Does
The Thyroid Disease CARE Act directs HHS, in consultation with the National Academies, to conduct or support research on thyroid disease root causes, diagnostic techniques, treatments, thyroid cancer care, survivorship, symptom management, disparities, and persistent symptoms despite normal test results, with an interim public report within 24 months. It separately requires analysis of research gaps and disproportionate impacts by race, ethnicity, geography, primary language, sex, sexual orientation, gender identity, disability, and insurance status, with particular focus on women, specialized-care access, provider knowledge, and payment options using Medicaid, CHIP, SEER, Medicare, private insurance, FEHBP, surveys, and other data. HHS must run a public awareness campaign for symptoms, treatment options, pregnancy and reproductive-stage screening, evidence-based care, implicit-bias prevention, and professional education, and may work through nonprofits, consumer groups, universities, and public-private partnerships. The bill authorizes 30 million dollars per year for each of fiscal years 2026 through 2030 for research, 30 million dollars per year for analysis, and 3 million dollars per year for awareness, and requires collaboration with professional societies and HHS agencies including NIH.
Who Benefits and How
People with thyroid disease, thyroid cancer patients, women of reproductive age, underserved communities, health care professionals, researchers, universities, nonprofits, and professional societies benefit from research funding, disparity analysis, awareness materials, data access, and evidence-based care guidance.
Who Bears the Burden and How
HHS staff, NIH researchers, National Academies partners, insurers, Medicaid and CHIP programs, Medicare data teams, FEHBP plans, health systems, and federal taxpayers must comply with research, reporting, data-request, campaign, collaboration, and funding obligations.
Key Provisions
- Authorizes HHS research on thyroid disease root causes, diagnostics, treatment, cancer care, survivorship, symptoms, and disparities.
- Requires analysis of thyroid research gaps, disproportionate impacts, care access, provider knowledge, and payment options.
- Funds a public awareness campaign for symptoms, treatment options, screening, evidence-based care, and implicit-bias prevention.
- Requires collaboration with professional societies, NIH, and other HHS agencies.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Authorizes HHS thyroid-disease research, disparity analysis, public awareness, professional education, and collaboration with professional societies, NIH, and National Academies partners, including 30 million dollars per year for research and analysis and 3 million dollars per year for awareness from fiscal years 2026 through 2030.
Key Policy Areas
Healthcare, Research & Science, Government, Education
Primary Purpose
Authorizes HHS thyroid-disease research, disparity analysis, public awareness, professional education, and collaboration with professional societies, NIH, and National Academies partners, including 30 million dollars per year for research and analysis and 3 million dollars per year for awareness from fiscal years 2026 through 2030.
Policy Domains
Substantive provisions
Identified Gains
- People with thyroid disease
- Thyroid cancer patients
- Women of reproductive age
- Underserved communities
- Health care professionals
Identified Costs
- HHS staff
- NIH researchers
- Health insurers
- Medicaid programs
- Federal taxpayers
Sponsors
Legislative Progress
In CommitteeMs. Stevens (for herself and Ms. Underwood) introduced the following …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Health care professionals, Health insurers, Medicaid programs
Positive-direction: Health care professionals, People with thyroid disease, Pregnant patients, Professional medical societies, Thyroid cancer patients, Underserved thyroid patients, Women affected by thyroid disease, Women of reproductive age
Negative-direction: Health insurers, Medicaid programs
HHS communications staff, HHS data analysts, HHS research staff
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology